The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient-reported outcomes (PRO) from a global phase 3 randomized controlled trial (RCT) of inotuzumab ozogamicin (InO) vs standard care (SC) for relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL).
 
Hagop M Kantarjian
Research Funding - Amgen; Astex Pharmaceuticals; Bristol-Myers Squibb; Novartis; Pfizer
 
Yun Su
Employment - Bristol-Myers Squibb; Pfizer
Stock and Other Ownership Interests - Bristol-Myers Squibb; Pfizer
 
Helen Bhattacharyya
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Eric Yan
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Mark Shapiro
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Joseph C Cappelleri
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer